azathioprine

TERMINATED · PHASE3 · Lung Disease, Pulmonary Fibrosis

Study design changes were needed based on GIPF-001 results

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.